State Street Corp Sema4 Holdings Corp. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.24 - $0.52 $229,668 - $497,614	956,950 Added 27.91%	4,385,223 $1.49 Million
Q4 2022 Feb 14, 2023	SELL	$0.22 - $1.04 $14,060 - $66,469	-63,913 Reduced 1.83%	3,428,273 $891,000
Q3 2022 Nov 15, 2022	BUY	$0.25 - $2.4 $49,166 - $472,000	196,667 Added 5.97%	3,492,186 $3.06 Million
Q2 2022 Aug 15, 2022	BUY	$1.22 - $3.05 $2.63 Million - $6.58 Million	2,157,989 Added 189.71%	3,295,519 $4.15 Million
Q1 2022 May 16, 2022	BUY	$2.64 - $4.67 $1.37 Million - $2.42 Million	518,620 Added 83.8%	1,137,530 $3.49 Million
Q4 2021 Feb 14, 2022	BUY	$4.4 - $8.8 $1.02 Million - $2.04 Million	231,410 Added 59.72%	618,910 $2.76 Million
Q3 2021 Nov 15, 2021	BUY	$7.44 - $13.99 $2.88 Million - $5.42 Million	387,500 New	387,500 $2.94 Million

166K

Ticker SMFR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 380,641,984
Market Cap $129M
Description
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.